Pelthos Therapeutics Inc.
PTHS • AMEX
Pelthos Therapeutics Inc. is a biological products, (no disgnostic substances) company trading on AMEX, led by CEO Scott Plesha, with a market cap of $75.5M.
Market Cap$75.5M
Employees11.0
CEOScott Plesha
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Next EarningsMay 9, 2026 · In 4 weeksQ1 2026
Financials
PTH
Pelthos Therapeutics Inc. FAQ
Common questions about Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. is scheduled to report earnings for Q1 2026 on May 9, 2026. Analysts estimate revenue of $10.2M.
Pelthos Therapeutics Inc. has approximately 11 employees.